Redefining the ASCVD management through Effective & Sustained LDL-C reduction with siRNA
9 min 9 sec

LDL-C is the Primary Target for ASCVD: Treat Early, Treat-to-Target, Treat Lifelong

ASSOC. PROF. PATTARAPONG MAKARAWATE, MD
Cardiologist, Khon Kaen University Hospital

11 min 41 sec

CASE SHARING: Managing CCS with a History of MI

ASST. PROF. NARATHIP CHUNHAMANEEWAT, MD
Cardiologist, Siriraj Hospital

 

 

 

7 min 39 sec

Prevent the Future CV Event in DM HIGH-RISK PATIENTS

ASSOC. PROF. PIMJAI ANTHANONT, MD
Endocrinologist, Thammasat University Hospital

10 min 29 sec

Q&A

14 min 32 sec

CASE SHARING: Young Hearts, Multi-Vessel Disease

KRISSADA MEEMOOK, MD
Cardiologist, Ramathibodi Hospital

5 min 15 sec

Long-Lasting LDL-C Control in ASCVD Patients

KRISSADA MEEMOOK, MD
Cardiologist, Ramathibodi Hospital

ASST. PROF. NARATHIP CHUNHAMANEEWAT, MD
Cardiologist, Siriraj Hospital

7 min 52 sec

CASE SHARING: DM High-Risk

ASST. PROF. SIRA KORPAISARN, MD
Endocrinologist, Ramathibodi Hospital